The global peptide microarray market size is expected to reach USD 1,133.5 million by 2030, registering a CAGR of 4.51% over the forecast period. The market is expected to witness a stable growth rate during the forecast period. The technique includes high throughput technologies in the area of clinical assays and proteomics. Peptide microarray can be analyzed through spectroscopy, mass spectrometry, and imaging via fluorescence. It has considerable applications in the field of medicine, pharmacology, and biology. It is one of the automated advanced technologies to collect a large volume of data from an experiment employed for therapeutic discoveries, disease diagnosis, and diagnostic technique development.
The method is employed to identify new drug targets. To detect the antigen present on the protein surface of bacteria, determination of Abs, immunogenic Identification, mapping of the epitope, biomarker validation, serum profiling, enzyme characterization, and HLA profiling are some of the applications of the peptide microarray. The use of peptide microarray for developing diagnostic tests is considered to be an important determinant of industry growth. According to research published in March 2021, peptide microarray can offer significant insights into the antigens for developing the COVID-19-based diagnostic test. Researchers used peptide microarrays to screen the samples for antibodies against the virus. Hence, the development of peptide microarray-based tests is expected to boost industry growth.
For instance, JPT Peptide Technologies commercializes peptide microarray for COVID-19 and infectious conditions at the retail price of USD 324. The technology can be used for immune detection and monitoring, biomarker discovery, and protein interaction validation. Key players are focusing on strategic initiatives to establish a strong distribution network across the globe. For instance, PEPperPRINT GmbH created its presence in the Asia Pacific regional market through distributors such as 4A Biotech Co., Ltd., Filgen, Inc., Tokyo Future Style, Inc., AbClon Inc., Tokyo Future Style Taiwan, Inc., Sciencewerke Co., Ltd., and TrendBio. The company adopted an indirect distribution strategy in the region. The strategy assisted the company to avoid the costs of regulatory compliance and customer acquisitions.
This product will be delivered within 1-3 business days.
The method is employed to identify new drug targets. To detect the antigen present on the protein surface of bacteria, determination of Abs, immunogenic Identification, mapping of the epitope, biomarker validation, serum profiling, enzyme characterization, and HLA profiling are some of the applications of the peptide microarray. The use of peptide microarray for developing diagnostic tests is considered to be an important determinant of industry growth. According to research published in March 2021, peptide microarray can offer significant insights into the antigens for developing the COVID-19-based diagnostic test. Researchers used peptide microarrays to screen the samples for antibodies against the virus. Hence, the development of peptide microarray-based tests is expected to boost industry growth.
For instance, JPT Peptide Technologies commercializes peptide microarray for COVID-19 and infectious conditions at the retail price of USD 324. The technology can be used for immune detection and monitoring, biomarker discovery, and protein interaction validation. Key players are focusing on strategic initiatives to establish a strong distribution network across the globe. For instance, PEPperPRINT GmbH created its presence in the Asia Pacific regional market through distributors such as 4A Biotech Co., Ltd., Filgen, Inc., Tokyo Future Style, Inc., AbClon Inc., Tokyo Future Style Taiwan, Inc., Sciencewerke Co., Ltd., and TrendBio. The company adopted an indirect distribution strategy in the region. The strategy assisted the company to avoid the costs of regulatory compliance and customer acquisitions.
Peptide Microarray Market Report Highlights
- The instruments type segment is relatively more mature than the services segment and held the largest share in 2022 due to the high number of pharma & biotech companies establishing in-house research stations for antibody-based research
- The disease diagnostics application segment captured the largest revenue share in 2022 owing to the high incidence of infectious diseases in emerging markets. For instance, PEPperPRINT GmbH offers peptide microarray for over 32 infectious conditions
- The pharmaceutical & biotechnology companies end-user segment held the maximum revenue share in 2022 due to the wide use of antibody characterization and validation of protein interactions
- North America accounted for the largest share of the overall revenue in 2022 due to the well-established healthcare facilities in this region along with increased investment in the R&D sector
- The rising awareness among healthcare professionals and patients about the early detection and treatment of chronic diseases also speeds up diagnostic capabilities and boosts the region’s growth
- Moreover, the increasing incidence of diseases, such as chronic and infectious diseases, is encouraging companies to enter the regional market
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology And Scope1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation And Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends And Outlook
3.4. Market Dynamics
3.4.1. Growing Burden Of Chronic Diseases
3.4.2. Technological Advancements In Diagnostic Testing
3.4.3. Rising Adoption For Peptide Microarrays
3.5. Market Restraint Analysis
3.5.1. Reimbursement Issues
3.6. Penetration And Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. Swot Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. Covid-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Peptide Microarray Market: Type Movement Analysis
4.2. Instruments
4.2.1. Peptide Microarray Market For Instruments, 2018 - 2030 (USD Million)
4.3. Reagents
4.3.1. Peptide Microarray Market For Reagents, 2018 - 2030 (USD Million)
4.4. Services
4.4.1. Peptide Microarray Market For Services, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Peptide Microarray Market: Application Movement Analysis
5.2. Disease Diagnostics
5.2.1. Peptide Microarray Market For Di
5.2.2. Sease Diagnostics, 2018 - 2030 (USD Million)
5.3. Protein Functional Analysis
5.3.1. Peptide Microarray Market For Protein Functional Analysis, 2018 - 2030 (USD Million)
5.4. Antibody Characterization
5.4.1. Peptide Microarray Market For Antibody Characterization, 2018 - 2030 (USD Million)
5.5. Drug Discovery
5.5.1. Peptide Microarray Market For Drug Discovery, 2018 - 2030 (USD Million)
Chapter 6. End-User Business Analysis
6.1. Peptide Microarray Market: End-User Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Peptide Microarray Market For Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
6.3. Hospitals & Clinics
6.3.1. Peptide Microarray Market For Hospitals & Clinics, 2018 - 2030 (USD Million)
6.4. Diagnostic Centers
6.4.1. Peptide Microarray Market For Diagnostic Centers, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Peptide Microarray Market For Others, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Peptide Microarray Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. Swot Analysis
7.2.2. North America Peptide Microarray Market, By Type, 2018 - 2030 (USD Million)
7.2.3. North America Peptide Microarray Market, By Application, 2018 - 2030 (USD Million)
7.2.4. North America Peptide Microarray Market, By End-User, 2018 - 2030 (USD Million)
7.2.5. U.S.
7.2.5.1. Key Country Dynamics
7.2.5.2. Target Disease Prevalence
7.2.5.3. Competitive Scenario
7.2.5.4. Regulatory Framework
7.2.5.5. Reimbursement Scenario
7.2.5.6. U.S. Peptide Microarray Market, 2018 - 2030 (USD Million)
7.2.6. Canada
7.2.6.1. Key Country Dynamics
7.2.6.2. Target Disease Prevalence
7.2.6.3. Competitive Scenario
7.2.6.4. Regulatory Framework
7.2.6.5. Reimbursement Scenario
7.2.6.6. Canada Peptide Microarray Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Swot Analysis
7.3.2. Europe Peptide Microarray Market, By Type, 2018 - 2030 (USD Million)
7.3.3. Europe Peptide Microarray Market, By Application, 2018 - 2030 (USD Million)
7.3.4. Europe Peptide Microarray Market, By End-User, 2018 - 2030 (USD Million)
7.3.5. Germany
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. Germany Peptide Microarray Market, 2018 - 2030 (USD Million)
7.3.6. U.K.
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. U.K. Peptide Microarray Market, 2018 - 2030 (USD Million)
7.3.7. France
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. France Peptide Microarray Market, 2018 - 2030 (USD Million)
7.3.8. Italy
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Italy Peptide Microarray Market, 2018 - 2030 (USD Million)
7.3.9. Spain
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Spain Peptide Microarray Market, 2018 - 2030 (USD Million)
7.3.10. Denmark
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Reimbursement Scenario
7.3.10.6. Denmark Peptide Microarray Market, 2018 - 2030 (USD Million)
7.3.11. Sweden
7.3.11.1. Key Country Dynamics
7.3.11.2. Target Disease Prevalence
7.3.11.3. Competitive Scenario
7.3.11.4. Regulatory Framework
7.3.11.5. Reimbursement Scenario
7.3.11.6. Sweden Peptide Microarray Market, 2018 - 2030 (USD Million)
7.3.12. Norway
7.3.12.1. Key Country Dynamics
7.3.12.2. Target Disease Prevalence
7.3.12.3. Competitive Scenario
7.3.12.4. Regulatory Framework
7.3.12.5. Reimbursement Scenario
7.3.12.6. Norway Peptide Microarray Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Swot Analysis
7.4.2. Asia Pacific Peptide Microarray Market, By Type, 2018 - 2030 (USD Million)
7.4.3. Asia Pacific Peptide Microarray Market, By Application, 2018 - 2030 (USD Million)
7.4.4. Asia Pacific Peptide Microarray Market, By End-User, 2018 - 2030 (USD Million)
7.4.5. Japan
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. Japan Peptide Microarray Market, 2018 - 2030 (USD Million)
7.4.6. China
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. China Peptide Microarray Market, 2018 - 2030 (USD Million)
7.4.7. India
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. India Peptide Microarray Market, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Reimbursement Scenario
7.4.8.6. South Korea Peptide Microarray Market, 2018 - 2030 (USD Million)
7.4.9. Australia
7.4.9.1. Key Country Dynamics
7.4.9.2. Target Disease Prevalence
7.4.9.3. Competitive Scenario
7.4.9.4. Regulatory Framework
7.4.9.5. Reimbursement Scenario
7.4.9.6. Australia Peptide Microarray Market, 2018 - 2030 (USD Million)
7.4.10. Thailand
7.4.10.1. Key Country Dynamics
7.4.10.2. Target Disease Prevalence
7.4.10.3. Competitive Scenario
7.4.10.4. Regulatory Framework
7.4.10.5. Reimbursement Scenario
7.4.10.6. Thailand Peptide Microarray Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Swot Analysis
7.5.2. Latin America Peptide Microarray Market, By Type, 2018 - 2030 (USD Million)
7.5.3. Latin America Peptide Microarray Market, By Application, 2018 - 2030 (USD Million)
7.5.4. Latin America Peptide Microarray Market, By End-User, 2018 - 2030 (USD Million)
7.5.5. Brazil
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Reimbursement Scenario
7.5.5.6. Brazil Peptide Microarray Market, 2018 - 2030 (USD Million)
7.5.6. Mexico
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Competitive Scenario
7.5.6.4. Regulatory Framework
7.5.6.5. Reimbursement Scenario
7.5.6.6. Mexico Peptide Microarray Market, 2018 - 2030 (USD Million)
7.5.7. Argentina
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Competitive Scenario
7.5.7.4. Regulatory Framework
7.5.7.5. Reimbursement Scenario
7.5.7.6. Argentina Peptide Microarray Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. Swot Analysis
7.6.2. MEA Peptide Microarray Market, By Type, 2018 - 2030 (USD Million)
7.6.3. MEA Peptide Microarray Market, By Application, 2018 - 2030 (USD Million)
7.6.4. MEA Peptide Microarray Market, By End-User, 2018 - 2030 (USD Million)
7.6.5. South Africa
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. South Africa Peptide Microarray Market, 2018 - 2030 (USD Million)
7.6.6. Saudi Arabia
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Reimbursement Scenario
7.6.6.6. Saudi Arabia Peptide Microarray Market, 2018 - 2030 (USD Million)
7.6.7. UAE
7.6.7.1. Key Country Dynamics
7.6.7.2. Target Disease Prevalence
7.6.7.3. Competitive Scenario
7.6.7.4. Regulatory Framework
7.6.7.5. Reimbursement Scenario
7.6.7.6. UAE Peptide Microarray Market, 2018 - 2030 (USD Million)
7.6.8. Kuwait
7.6.8.1. Key Country Dynamics
7.6.8.2. Target Disease Prevalence
7.6.8.3. Competitive Scenario
7.6.8.4. Regulatory Framework
7.6.8.5. Reimbursement Scenario
7.6.8.6. Kuwait Peptide Microarray Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant’s Overview
8.2. Financial Performance
8.3. Participant Categorization
8.3.1. Market Leaders
8.3.2. Peptide Microarray Market Share Analysis, 2022
8.3.3. Company Profiles
8.3.3.1. Pepperprint Gmbh
8.3.3.2. Raybiotech Life, Inc.
8.3.3.3. Creative Biolabs
8.3.3.4. Aurora Instruments Ltd.
8.3.3.5. Kinexus Bioinformatics Corporation
8.3.3.6. Bio-Synthesis
8.3.3.7. Microarrays Inc.
8.3.3.8. Bio-Rad Laboratories
8.3.3.9. Jpt Peptide Technologies
8.3.3.10. Merck Kgaa
8.3.3.11. Innopsys
8.3.4. Strategy Mapping
8.3.4.1. Expansion
8.3.4.2. Acquisition
8.3.4.3. Collaborations
8.3.4.4. Product/Service Launch
8.3.4.5. Partnerships
8.3.4.6. Others
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 4 Global Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 5 Global Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 6 North America Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 7 North America Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 8 North America Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 9 North America Peptide microarray market by Country, 2018 - 2030 (USD Million)
Table 10 U.S. Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 11 U.S. Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 12 U.S. Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 13 Canada Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 14 Canada Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 15 Canada Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 16 Europe Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 17 Europe Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 18 Europe Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 19 Europe Peptide microarray market by Country, 2018 - 2030 (USD Million)
Table 20 U.K. Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 21 U.K. Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 22 U.K. Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 23 Germany Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 24 Germany Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 25 Germany Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 26 France Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 27 France Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 28 France Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 29 Italy Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 30 Italy Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 31 Italy Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 32 Spain Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 33 Spain Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 34 Spain Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 35 Denmark Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 36 Denmark Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 37 Denmark Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 38 Sweden Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 39 Sweden Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 40 Sweden Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 41 Norway Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 42 Norway Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 43 Norway Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Peptide microarray market by Country, 2018 - 2030 (USD Million)
Table 48 China Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 49 China Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 50 China Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 51 Japan Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 52 Japan Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 53 Japan Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 54 India Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 55 India Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 56 India Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 57 Australia Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 58 Australia Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 59 Australia Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 60 Thailand Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 61 Thailand Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 62 Thailand Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 63 South Korea Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 64 South Korea Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 65 South Korea Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 66 Latin America Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 67 Latin America Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 68 Latin America Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 69 Latin America Peptide microarray market by Country, 2018 - 2030 (USD Million)
Table 70 Brazil Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 71 Brazil Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 72 Brazil Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 73 Mexico Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 74 Mexico Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 75 Mexico Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 76 Argentina Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 77 Argentina Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 78 Argentina Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Peptide microarray market by Country, 2018 - 2030 (USD Million)
Table 83 South Africa Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 84 South Africa Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 85 South Africa Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 89 UAE Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 90 UAE Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 91 UAE Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 92 Kuwait Peptide microarray market by Type, 2018 - 2030 (USD Million)
Table 93 Kuwait Peptide microarray market by Application, 2018 - 2030 (USD Million)
Table 94 Kuwait Peptide microarray market by End-user, 2018 - 2030 (USD Million)
Table 95 Participant’s overview
Table 96 Financial performance
Table 97 Key companies undergoing expansions
Table 98 Key companies undergoing acquisitions
Table 99 Key companies undergoing collaborations
Table 100 Key companies launching new products/services
Table 101 Key companies undergoing partnerships
Table 102 Key companies undertaking other strategies
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2022 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s analysis
Fig. 14 SWOT analysis
Fig. 15 Peptide microarray market: Type outlook and key takeaways
Fig. 16 Peptide microarray market: Type movement analysis
Fig. 17 Global instruments market, 2018 - 2030 (USD Million)
Fig. 18 Global reagents market, 2018 - 2030 (USD Million)
Fig. 19 Global services market, 2018 - 2030 (USD Million)
Fig. 20 Peptide microarray market: Application outlook and key takeaways
Fig. 21 Peptide microarray market: Application movement analysis
Fig. 22 Global disease diagnostics market, 2018 - 2030 (USD Million)
Fig. 23 Global protein functional analysis market, 2018 - 2030 (USD Million)
Fig. 24 Global antibody characterization market, 2018 - 2030 (USD Million)
Fig. 25 Global drug discovery market, 2018 - 2030 (USD Million)
Fig. 26 Peptide microarray market: End-user outlook and key takeaways
Fig. 27 Peptide microarray market: End-user movement analysis
Fig. 28 Global pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
Fig. 29 Global hospitals and clinics market, 2018 - 2030 (USD Million)
Fig. 30 Global diagnostic centers market, 2018 - 2030 (USD Million)
Fig. 31 Global others market, 2018 - 2030 (USD Million)
Fig. 32 Peptide microarray market: Regional outlook and key takeaways
Fig. 33 North America: SWOT Analysis
Fig. 34 North America Peptide microarray market, 2018 - 2030 (USD Million)
Fig. 35 US key country dynamics
Fig. 36 US Peptide microarray market, 2018 - 2030 (USD Million)
Fig. 37 Canada key country dynamics
Fig. 38 Canada Peptide microarray market, 2018 - 2030 (USD Million)
Fig. 39 Europe: SWOT Analysis
Fig. 40 Europe Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Germany key country dynamics
Fig. 42 Germany Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 France key country dynamics
Fig. 44 France Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 UK key country dynamics
Fig. 46 UK Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Italy key country dynamics
Fig. 48 Italy Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Spain key country dynamics
Fig. 50 Spain Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Denmark key country dynamics
Fig. 52 Denmark Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Sweden key country dynamics
Fig. 54 Sweden Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Norway key country dynamics
Fig. 56 Norway Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Rest of Europe key country dynamics
Fig. 58 Rest of Europe Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Asia-Pacific: SWOT Analysis
Fig. 60 Asia-Pacific Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 China key country dynamics
Fig. 62 China Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 India key country dynamics
Fig. 64 India Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 South Korea key country dynamics
Fig. 66 South Korea Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Japan key country dynamics
Fig. 68 Japan Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Australia key country dynamics
Fig. 70 Australia Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Thailand key country dynamics
Fig. 72 Thailand Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Rest of APAC key country dynamics
Fig. 74 Rest of APAC Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Latin America: SWOT Analysis
Fig. 76 Latin America Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Brazil key country dynamics
Fig. 78 Brazil Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Mexico key country dynamics
Fig. 80 Mexico Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Argentina key country dynamics
Fig. 82 Argentina Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Rest of LATAM key country dynamics
Fig. 84 Rest of LATAM Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 MEA: SWOT Analysis
Fig. 86 MEA Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 South Africa key country dynamics
Fig. 88 South Africa Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Saudi Arabia key country dynamics
Fig. 90 Saudi Arabia Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 UAE key country dynamics
Fig. 92 UAE Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 93 Kuwait key country dynamics
Fig. 94 Kuwait Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 95 Rest of MEA key country dynamics
Fig. 96 Rest of MEA Peptide microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 97 Heat map analysis
Fig. 98 Market participant categorization
Fig. 99 Peptide microarray market share analysis, 2022
Fig. 100 Strategy framework
Companies Mentioned
- Pepperprint Gmbh
- Raybiotech Life, Inc.
- Creative Biolabs
- Aurora Instruments Ltd.
- Kinexus Bioinformatics Corporation
- Bio-Synthesis
- Microarrays Inc.
- Bio-Rad Laboratories
- Jpt Peptide Technologies
- Merck Kgaa
- Innopsys
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | January 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 832.5 Million |
| Forecasted Market Value ( USD | $ 1133.5 Million |
| Compound Annual Growth Rate | 4.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
